T1	Participants 43 79	patients with advanced larynx cancer
T2	Participants 186 222	patients with advanced larynx cancer
T3	Participants 277 350	112 patients with advanced larynx cancer after radical surgical treatment
T4	Participants 352 435	Patients had postoperative radiation therapy, conventional (C) or accelerated (CB).
T5	Participants 778 891	Patients with close surgical margins, longer interval between surgery and radiation, high level of hemoglobin, T4
